Financhill
Sell
29

INO Quote, Financials, Valuation and Earnings

Last price:
$1.92
Seasonality move :
2.57%
Day range:
$1.88 - $1.98
52-week range:
$1.74 - $14.75
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
1.03x
Volume:
2M
Avg. volume:
714K
1-year change:
-82.51%
Market cap:
$70.4M
Revenue:
$217.8K
EPS (TTM):
-$3.99

Earnings Data

Next earnings date for INO
May 13
2025
Most recent earnings per share
-$0.60
Beat by $0.23
(Mar 18/2025)
Consensus Estimate
-$0.83
(Mar 18/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

INO Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
05/13/2025 Q1 $10K -- -- -$0.74 --
03/18/2025 Q4 $25K $117K -$0.60 -$0.83 $0.23
11/14/2024 Q3 $104.5K -- -$0.89 -$1.13 $0.24
08/08/2024 Q2 $121.5K $100.8K -$1.19 -$1.10 -$0.09
05/13/2024 Q1 $150.8K -- -$1.31 -$0.99 -$0.32
03/06/2024 Q4 $344.1K $102.7K -$1.08 -$1.24 $0.16
11/09/2023 Q3 $262.5K $388.5K -$1.52 -$1.50 -$0.02
08/09/2023 Q2 $262.5K $226K -$1.61 -$1.72 $0.11
05/10/2023 Q1 $275K $114.9K -$1.89 -$1.80 -$0.09
03/01/2023 Q4 -- $124.7K -$2.55 -- --
11/08/2022 Q3 -- $9.2M -$1.80 -- --
08/09/2022 Q2 -- $784.4K -$5.52 -- --
05/10/2022 Q1 -- $199.1K -$4.32 -- --
03/01/2022 Q4 -- $839.1K -$6.05 -- --
11/09/2021 Q3 -- $291.7K -$3.48 -- --
08/09/2021 Q2 -- $272.8K -$4.68 -- --
05/10/2021 Q1 -- $371.1K -$3.24 -- --
03/01/2021 Q4 -- $5.6M -$1.32 -- --
11/09/2020 Q3 -- $236.2K $1.32 -- --
08/10/2020 Q2 -- $267.2K -$9.96 -- --
05/11/2020 Q1 -- $1.3M -$3.12 -- --
03/12/2020 Q4 -- $279.5K -$4.56 -- --
11/12/2019 Q3 -- $866.9K -$3.00 -- --
08/08/2019 Q2 -- $135.7K -$3.60 -- --
05/09/2019 Q1 -- $2.8M -$3.60 -- --
03/12/2019 Q4 -- $2.5M -$4.20 -- --
11/08/2018 Q3 -- $2M -$3.24 -- --
08/07/2018 Q2 -- $24.4M -$0.96 -- --
05/09/2018 Q1 -- $1.5M -$4.32 -- --
03/14/2018 Q4 -- $8.8M -$2.88 -- --
11/08/2017 Q3 -- $2.6M -$4.80 -- --
08/08/2017 Q2 -- $20.4M -$1.56 -- --
05/10/2017 Q1 -- $10.4M -$3.72 -- --
03/15/2017 Q4 -- $8.5M -$4.32 -- --
11/09/2016 Q3 -- $12.5M -$3.36 -- --
08/08/2016 Q2 -- $6.2M -$3.12 -- --
05/09/2016 Q1 -- $8.1M -$1.32 -- --
03/14/2016 Q4 -- $5.9M -$3.12 -- --
11/09/2015 Q3 -- $24.2M $0.84 -- --
08/10/2015 Q2 -- $5.3M -$1.08 -- --
05/11/2015 Q1 -- $5.2M -$2.16 -- --

Inovio Pharmaceuticals Earnings Questions

  • How Much did Inovio Pharmaceuticals Generate in Revenue Last Quarter?

    Inovio Pharmaceuticals reported $117K worth of top line sales in its most recent quarter.

  • Did Inovio Pharmaceuticals Beat Earnings Last Quarter?

    Inovio Pharmaceuticals announced earnings per share of -$0.60 which represents a beat of analyst forecast a -$0.83 per share.

  • Is Inovio Pharmaceuticals Profitable?

    Inovio Pharmaceuticals reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for Inovio Pharmaceuticals EPS Next Year?

    Inovio Pharmaceuticals's earnings are forecast to decrease from -$3.95 per share to -$4.21 per share next year representing a decrease of -36.01%.

  • When is Inovio Pharmaceuticals's Earnings Date?

    Inovio Pharmaceuticals's next earnings date is May 13, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Amazon Stock Still Worth Staking On?
Is Amazon Stock Still Worth Staking On?

Amazon.com Inc (NASDAQ: AMZN) posted one of its strongest years…

Is Palantir a Good Stock to Buy?
Is Palantir a Good Stock to Buy?

Palantir Technologies (PLTR) stock soared to its highest level in…

Why Is Sportradar Stock Going Up?
Why Is Sportradar Stock Going Up?

Sportradar (NASDAQ:SRAD) should be on your radar for a stock…

Stock Ideas

Buy
55
Is AAPL Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 36x

Buy
53
Is MSFT Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 33x

Buy
51
Is NVDA Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 40x

Alerts

Sell
50
RGC alert for Mar 22

Regencell Bioscience Holdings [RGC] is up 27.82% over the past day.

Sell
36
VMI alert for Mar 22

Valmont Industries [VMI] is down 12.54% over the past day.

Buy
61
ALNY alert for Mar 22

Alnylam Pharmaceuticals [ALNY] is up 11.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock